I
Iterum Therapeutics plc (ITRM)
NCM – Real vaqt narxi. Valyuta: USD
0.04
-0.14 (-79.77%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.04
+0.00 (3.65%)
Bozordan keyin: Mar 27, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NCM – Real vaqt narxi. Valyuta: USD
0.04
-0.14 (-79.77%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.04
+0.00 (3.65%)
Bozordan keyin: Mar 27, 2026, 7:59 PM EDT
Iterum Therapeutics plc, farmatsevtika kompaniyasi, Irlandiya, Bermud orollari va Qo'shma Shtatlarda dori-darmonga chidamli bakterial infektsiyalarni davolash uchun vositalarni ishlab chiqadi va tijoratlashtiradi. Kompaniya ORLYNVAHni taklif etadi, bu Escherichia coli, Klebsiella pneumoniae va Proteus mirabilis mikroorganizmlari tomonidan qo'zg'atilgan murakkab bo'lmagan siydik yo'llari infektsiyalarini davolash uchun og'iz orqali yuboriladigan penem antibiotikidir, bu cheklangan yoki umuman muqobil og'iz orqali antibakterial davolash variantlari bo'lmagan kattalar ayollar uchun mo'ljallangan. Kompaniya shuningdek, murakkab bo'lmagan siydik yo'llari infektsiyalari, murakkab siydik yo'llari infektsiyalari va murakkab qorin ichi infektsiyalari, shuningdek, jamiyatda orttirilgan bakterial pnevmoniya, o'tkir bakterial prostatit, gonokokk uretriti va tos a'zolari yallig'lanish kasalliklarini davolash uchun og'iz va tomir ichiga yuboriladigan yangi antiinfektsion birikma bo'lgan sulopenemni ishlab chiqmoqda. Iterum Therapeutics plc 2015 yilda tashkil etilgan va Dublin, Irlandiyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Michael W. Dunne M.D. | Strategic Advisor & Director |
| Dr. Steven I. Aronin M.D. | Senior VP & Head of Clinical Development |
| Kevin Dalton | Senior Director of Legal Affairs & Company Secretary |
| Mr. Corey N. Fishman | President, CEO & Director |
| Mr. Tom Loughman Ph.D. | Senior Vice President of Technical Operations |
| Ms. Christine R. Coyne M.B.A. | Chief Commercial Officer |
| Ms. Judith M. Matthews | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-03 | 8-K | itrm-20260303.htm |
| 2026-03-02 | 8-K | itrm-20260224.htm |
| 2026-01-26 | DEFA14A | itrm-20260126.htm |
| 2026-01-02 | DEF 14A | itrm-20260102.htm |
| 2025-12-23 | PRE 14A | itrm-20251223.htm |
| 2025-12-12 | 8-K | itrm-20251211.htm |
| 2025-11-14 | 10-Q | itrm-20250930.htm |
| 2025-10-16 | 8-K | d933718d8k.htm |
| 2025-09-10 | 8-K | itrm-20250910.htm |
| 2025-08-28 | 8-K | itrm-20250825.htm |